Skip to main content

Global IVD Contract Manufacturing Services Market Forecasts 11% CAGR Driven by Testing by 2030

 The global IVD contract manufacturing services market is set to witness a growth rate of ~11% during the forecast period. Growing preference for point-of-care testing services; government support to scale up production of IVD kits post COVID-19 pandemic; growing incidence of cancer and infectious diseases; and advantages such as cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers are some of the key factors driving the market growth. 

In-vitro diagnostics (IVD) are tests done on samples such as blood or tissue to detect diseases or other conditions. It is used to monitor a person’s overall health to help cure, treat, or prevent diseases. Cost savings, scalability, technology know-how, and risk mitigation offered by IVD contract manufacturers drive OEMs' decision to outsource to IVD CDMOs.

Download a free sample report now 👉
 https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

Growing preference for point-of-care (POC) testing services fuels the growth of the IVD contract manufacturing services market

In an endeavor to cut result time and help patients make better-informed decisions about their health, there is considerable demand for IVD testing to move closer to the patient, i.e. point-of-care (POC) diagnostics, whether in the hospital, clinic, physician's office, or home. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges. For instance, the ability to process high-precision components that involve reagents and fluids are the most relevant capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs.

 “Rising demand for point-of-care IVD devices is a key driver for growth. Recently launched point-of-care IVD instruments and devices are convenient to use and efficient. Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges, which is addressed by IVD CDMOs.” - Director, Leading IVD OEM, United States

Cost savings, scalability, technology know-how and risk mitigation offered by IVD contract manufacturers drives their demand

By partnering with IVD contract manufacturers, OEMs can save costs on labor, automation and can achieve economies of scale at a relatively lower cost. OEMs prefer IVD CDMOs for their scalability, reliability, and cost-effective manufacturing capabilities. OEMs look for IVD CDMOs who have sound technical capabilities that are not part of their core competency. Mitigation of regulatory risks & supply disruption risks is other pivotal factors that urge OEMs to partner with IVD CDMOs. For instance,

  • In January 2025, Akoya Biosciences selected Argonaut Manufacturing Services as its contract manufacturing partner to support the production of in-vitro diagnostic (IVD) products, aiming to accelerate commercialization and expand its IVD offerings

  • In March 2024, Beckman Coulter and Fujirebio collaborated to co-develop patient-friendly, blood-based Alzheimer’s disease tests, leveraging Fujirebio’s IVD expertise and manufacturing capabilities

Growing incidence of cancer and infectious diseases & role of IVDs drives the IVD contract manufacturing services market

IVD plays a critical role in driving clinical decision-making for cancer screening, diagnosis, and treatment. IVD testing provides insights related to a patient’s health status such as risk or predisposition for developing certain cancer; the stage of disease, and the prognosis for progression/remission after therapy.

IVDs are also used to analyze human samples such as blood and saliva. It helps in measuring the concentration of specific substances/analytes, detects the presence or absence of a particular marker or set of markers in response to infection. Clinicians frequently use IVDs to diagnose infectious diseases, guide treatment decisions and even mitigate or prevent future diseases. Continuously rising cases of cancer and infectious diseases are likely to spur the IVD contract manufacturing services market.

Competitive Landscape Analysis

The IVD Contract Manufacturing Services market is marked by the presence of key players such as Jabil Inc., STRATEC, Celestica, Sanmina Corporation, Röchling, KMC Systems, Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Thermo Fisher Scientific Inc., Cenogenics Corporation, Coris BioConcept, Gerresheimer, and Phillips-Medisize, among others. Some of the key strategies adopted by market players include strategic partnerships and collaborations and geographic expansion.

Download a sample report for in-depth competitive insights
 https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/

 Global IVD Contract Manufacturing Services Market Segmentation

This report by Medi-Tech Insights provides the size of the global IVD contract manufacturing services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on service, technology, and end-user.

Market Size & Forecast (2023-2030), By Service, USD Million

  • Manufacturing Services

  • Assay Development Services

  • Others

Market Size & Forecast (2023-2030), By Technology, USD Million

  • Immunoassays

  • Clinical Chemistry

  • Molecular Diagnostics

  • Hematology

  • Microbiology

  • Coagulation

  • Others

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Medical Device Companies

  • Academic & Research Institutes

  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America

    • US

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe

  • Asia Pacific

    • China

    • India

    • Japan

    • Rest of Asia Pacific

  • Latin America

  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
  Associate, Medi-Tech Insights
  +32 498 86 80 79
  info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more